Obstetrics Gynecology – MD, MSC, MMSC, Phd – Fertility Specialist

Advanced Genomic Testing

In cooperation with Intergenetics which has developed a series of new advanced genomic tests,we are able to minimize the transmission of genetic diseases to our children or to treat unknown cause infertility hitherto impossible.


In almost 30% of unexplained infertility, it is likely for genetic abnormalities -usually not detectable by current methods- to underlie. Via the advanced technique NGS, more than 160 carefully selected genes are analyzed, which are known or suspected to be associated with various forms of male and / or female infertility, not attributable to the “classic” infertility causes.

Knowing the cause of infertility in a couple, with the identification of the responsible gene defect through the application of the test Fertilitis®, may authorize a custom reproduction protocol plan after appropriate clinical genetic evaluation in each case. As a consequence this can lead to the birth of a healthy child without the unnecessary hassle of stressful tests and costly procedures.


Progenomis® can analyse more than 650 genes in each of both future parents. These genes are involved in hundreds of serious “recessive” genetic diseases with a frequency of 1/200 births.

The carriers of these diseases are asymptomatic and there may be no family history. So even today, children are born suffering from these sex linkeddiseases and their diagnosis is made after birth.

Using Progenomis®, expectant parents can know in time if they are carriers of “recessive” genetic diseases. So they have the opportunity to give birth to a healthy child, using custom progenitor or preimplantation control.


DonoSafe® analyzes over 315 genes in one male or female donor/ recipient. It identifies several thousand of pathological mutations in more than 350 serious “recessive” genetic diseases which occur at a frequency of at least more than 1 in 200 births.

The carriers of these diseases are asymptomatic, have no family history and so far they could not be traced, so the diagnosis of these diseases in children is made after birth. The probability of a child being affected is ¼, but using DonoSafe® we can detect early any genetic problem.